Denver, CO, United States of America

Chris Glode

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chris Glode: Innovator in Genomic User Interfaces

Introduction

Chris Glode is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of genomics through his innovative work. With a focus on enhancing user interaction with genomic data, Glode has developed a unique approach to presenting complex information in an accessible manner.

Latest Patents

Chris Glode holds a patent for a "Genomic network service user interface." This invention involves a genomic update system that generates a user interface from network pages based on user variant data and associated network services. The system includes a trait data structure that tracks network services for various trait categories. This allows for the identification of different categories and services for display to users. The user interface can incorporate additional contextual visualizations, enabling users to interact with the content via handheld mobile devices. He has 1 patent to his name.

Career Highlights

Glode is currently employed at Helix Opco, LLC, where he continues to push the boundaries of genomic technology. His work focuses on creating user-friendly interfaces that facilitate the understanding of genomic data. This innovative approach has the potential to revolutionize how individuals interact with their genetic information.

Collaborations

Chris collaborates with talented professionals in his field, including Keith Dunaway and Anna Merkoulovitch. Their combined expertise contributes to the advancement of genomic technologies and user interface design.

Conclusion

In summary, Chris Glode is a pioneering inventor whose work in genomic user interfaces is shaping the future of how we engage with genetic data. His contributions are significant and reflect a commitment to innovation in the field of genomics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…